Should a company be permitted to patent a mutated human gene that can be targeted for therapy or an endogenous protein that they would like to produce as a therapeutic?

A five-point bulleted summary of the lecture pdf presented below (9-Pelleymounter-B…). Each bullet point should be approximately 5-7 sentences and concisely and accurately describe a major aspect of the lecture. *****The full summary should be no longer than one-page long. The goal of the exercise is to recognize the most important aspects of each lecture and effectively communicate them. ***I HAVE PROVIDED AN EXAMPLE OF HOW THE FLOW OF THE SUMMARY SHOULD SOUND LIKE. PLEASE FOLLOW THAT EXAMPLE STRICTLY.(1B Summary Example)
PROMPT: PLEASE SUMMARIZE WEEK 10B Raddatz- BioSimilars and 9A Calvo- Patent Law A POWERPOINT ( PLEASE DO NOT COPY IT WORD FOR WORD. PLEASE PARAPHRASE AND PUT THE IMPORTANT CONTENT IN THE SUMMARY)
Also write a 2 paragraph summary regarding this prompts:
1. Should a company be permitted to patent a mutated human gene that can be targeted for therapy or an endogenous protein that they would like to produce as a therapeutic?